Stock Track | Trevi Therapeutics Soars 5.27% in Intraday Trading After Stifel Raises Target Price to $30

Stock Track

05/08

Trevi Therapeutics, Inc. (TRVI) saw its stock price soar by 5.27% during intraday trading on Friday, reflecting a significant positive market reaction.

The surge appears to be driven by bullish analyst sentiment, specifically after Stifel raised its price target for the company from $18 to $30. This substantial increase in the target price indicates heightened optimism regarding the company's future financial performance and growth prospects.

Other analysts have also recently provided insights on Trevi Therapeutics, contributing to the positive sentiment in the healthcare sector surrounding the stock.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1147932153"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147932153\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147932153?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-08 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147932153","market":"nz","top_or_hot":-1,"title":"Stock Track | Trevi Therapeutics Soars 5.27% in Intraday Trading After Stifel Raises Target Price to $30","media":"Stock Track","content":"<p>Trevi Therapeutics, Inc. (TRVI) saw its stock price soar by 5.27% during intraday trading on Friday, reflecting a significant positive market reaction.</p><p>The surge appears to be driven by bullish analyst sentiment, specifically after Stifel raised its price target for the company from $18 to $30. This substantial increase in the target price indicates heightened optimism regarding the company's future financial performance and growth prospects.</p><p>Other analysts have also recently provided insights on Trevi Therapeutics, contributing to the positive sentiment in the healthcare sector surrounding the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Trevi Therapeutics Soars 5.27% in Intraday Trading After Stifel Raises Target Price to $30</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Trevi Therapeutics Soars 5.27% in Intraday Trading After Stifel Raises Target Price to $30\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-08 21:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Trevi Therapeutics, Inc. (TRVI) saw its stock price soar by 5.27% during intraday trading on Friday, reflecting a significant positive market reaction.</p><p>The surge appears to be driven by bullish analyst sentiment, specifically after Stifel raised its price target for the company from $18 to $30. This substantial increase in the target price indicates heightened optimism regarding the company's future financial performance and growth prospects.</p><p>Other analysts have also recently provided insights on Trevi Therapeutics, contributing to the positive sentiment in the healthcare sector surrounding the stock.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRVI","symbol_name":"Trevi Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1147932153","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147932153","pubTimestamp":1778247306,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Trevi Therapeutics, Inc. (TRVI) saw its stock price soar by 5.27% during intraday trading on Friday, reflecting a significant positive market reaction.The surge appears to be driven by bullish...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TRVI":"Trevi Therapeutics Inc."},"translate_title":"个股追踪|Stifel上调目标价至30美元后Trevi Therapeutics盘中大涨5.27%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TRVI":1},"content_text":"Trevi Therapeutics, Inc. (TRVI) saw its stock price soar by 5.27% during intraday trading on Friday, reflecting a significant positive market reaction.The surge appears to be driven by bullish analyst sentiment, specifically after Stifel raised its price target for the company from $18 to $30. This substantial increase in the target price indicates heightened optimism regarding the company's future financial performance and growth prospects.Other analysts have also recently provided insights on Trevi Therapeutics, contributing to the positive sentiment in the healthcare sector surrounding the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}